Vastagbélrák: vizsgálatok itt: Japán
47 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Chiba, Fukuoka, Hidaka, Kashiwa, Kitaadachi-Gun, Koto-ku, Nagaizumi-chō, Nagoya, Osaka, Yokohama
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Chūōku, Kashiwa, Kōtoku, Nagoya, Shinagawa-ku, Suita-shi
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 3. fázisTaking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Akashi-shi, Bunkyo-ku, Bunkyo Ku, Chiba, Chuo Ku, Fukuoka, Hirakata-shi, Kashiwa-shi, Kawasaki-shi, Kitaadachi-gun, Koto-ku, Matsuyama, Nagoya, Niigata, Osaka, Sapporo, Suita-shi, Sunto-gun, Tokushima, Yokohama
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649 - 1. fázisTaking peoplePhase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
- Where
- Chuo Ku
- Életkor
- 18 év and over
- People
- 66 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07630961 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1. fázisTaking peopleAB122 Platform Study
- Where
- Aichi, Chiba, Ehime, Hokkaido, Kanagawa, Osaka, Shizuoka, Tokyo, Wakayama
- Életkor
- 18 év and over
- People
- 917
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT04999761 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Chuo Ku, Kashiwa-shi, Nagoya
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 1. fázisTaking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Chiba, Tokyo
- Életkor
- 18 év and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - 2. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Where
- Hyōgo, Osaka
- Életkor
- 18 év and over
- People
- 144 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT06948448 - No phaseTaking peopleEarly Onset Colorectal Cancer Detection
- Where
- Kawasaki, Mie, Tokyo, Yamagata
- Életkor
- 18 év to 50 év
- People
- 400 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342401 - No phaseTaking peopleEarly Detection of Advanced Adenomas and Colorectal Cancer
- Where
- Mie
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342440 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- Where
- Chūōku, Kashiwa
- Életkor
- 18 év and over
- People
- 482 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07079631 · EU 2025-521768-36-00 - 1. fázisTaking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Chuo-ku, Hirakata-shi, Kashiwa-shi, Kobe, Nagoya, Sunto-gun, Wakayama
- Életkor
- 18 év and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 2. fázisTaking peopleA Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
- Where
- Osaka, Tokyo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06567782 - 3. fázisTaking peopleStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Aichi, Chiba, Fukuoka, Hokkaido, Hyōgo, Ibaraki, Kanagawa, Kyoto, Okayama, Osaka, Shizuoka, Tokyo
- Életkor
- 18 év and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00 - 1. fázisTaking peopleStudy of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer
- Where
- Koto-Ku
- Életkor
- 18 év and over
- People
- 48
- Run by
- Eiji Shinozaki
See details and how to joinNCT06853496 - 3. fázisTaking peopleTNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
- Where
- Chiba, Ehime, Fukuoka, Gifu, Hirosaki, Hiroshima, Kawasaki, Kitakyushu, Kochi, Kumamoto, Kyoto, Nagoya, Okayama, Osaka, Sagamihara, Sapporo, Tokyo, Yokohama, Yokosuka
- Életkor
- 18 év and over
- People
- 608
- Run by
- National Cancer Center Hospital East
See details and how to joinNCT05646511 - 2/3. fázisNot yet taking people in JapánA Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
- Where
- Kashiwa
- Életkor
- 18 év to 75 év
- People
- 568 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT04547166 - 2. fázisTaking peopleA Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer
- Where
- Osaka
- Életkor
- 18 év and over
- People
- 45
- Run by
- Osaka University
See details and how to joinNCT05939661 - 3. fázisTaking peopleSurgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
- Where
- Chiba, Gifu, Hidaka, Hirakata, Hiroshima, Izumo, Kanazawa, Kashiwa, Kawagoe, Kochi, Kumamoto, Kurashiki, Kurume, Matsuyama, Mitaka, Morioka, Nagoya, Niigata, Nishinomiya, Ōgaki, Okayama, Osaka, Ōta-ku, Saitama, Sapporo, Sendai, Shizuoka, Suita, Takatsuki, Tokorozawa, Tokyo, Utsunomiya, Yamagata, Yokohama, Yufu
- Életkor
- 20 év to 80 év
- People
- 110
- Run by
- National Cancer Center Hospital East
See details and how to joinNCT04288999